<DOC>
	<DOCNO>NCT00566150</DOCNO>
	<brief_summary>A 6-week outpatient , double-blind , placebo-controlled , add-on trial investigate effect levetiracetam depressive symptom bipolar depress patient .</brief_summary>
	<brief_title>Levetiracetam Management Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>DSMIV diagnosis bipolar disorder Presence current major depressive episode SCID Score 17 great HDRS Capable give voluntary write consent Significant current substance dependence/abuse within 3 month precede trial Active suicidal ideation Pregnant/lactating mother Significant medical history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Keppra</keyword>
	<keyword>Levetiracetam</keyword>
	<keyword>Anticonvulsant</keyword>
	<keyword>Depression</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Affective Disorders</keyword>
	<keyword>Mood Disorders</keyword>
	<keyword>Double Blind</keyword>
	<keyword>Acute Antidepressant Effects</keyword>
</DOC>